Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
about
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureRole of Transcatheter Intra-arterial Therapies for Hepatocellular CarcinomaSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaAdvanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma.Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spreadTreatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolizationHepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacyMicrotubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.Doxorubicin -eluting beads in the treatment of liver carcinoma.90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.Survival in unresectable AJCC stage I and II HCC and the effect of DEB-TACE: SEER versus tertiary cancer center cohort study.Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.Prospective longitudinal quality of life and survival outcomes in patients with advanced infiltrative hepatocellular carcinoma and portal vein thrombosis treated with Yttrium-90 radioembolization.Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.Tumor thrombus: incidence, imaging, prognosis and treatment.Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study.Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.Safety and efficacy of a circumferential clip-based vascular closure device in cirrhotic and coagulopathic patients with hepatocellular carcinoma after doxorubicin drug-eluting beads transarterial chemoembolization.
P2860
Q26771776-63A25C40-3060-439D-8B50-CA457AA2881AQ26851627-654B6CFF-4E6D-48D8-9809-0DC0E5194800Q27007847-3A7A258B-0392-48C9-889C-17EB80C94499Q28392783-6B52770E-5F68-487D-BD4A-0A82C0EC6653Q28394414-B3F0D3B4-D9DC-46AF-8A4A-53A0EA78BB6AQ33797067-A84177B8-8400-4489-8C85-C5052CACF8DFQ34826535-3B7F99C8-5D58-4793-9900-055794054155Q35411599-D07E2868-A85A-4D77-B296-44BCD9562422Q35553137-C917D5C1-4F1A-474D-971B-F81524F04B12Q36272834-E2DAFBAC-1796-4F18-88B1-23D3FA270731Q36720150-AD2944BA-C0E8-4986-9F7A-BCBFF456EF51Q37031737-FE544A28-3775-4B52-AF5F-FB4C2DF9D6EBQ37722656-3FFBEA4D-ADF6-4AE6-A289-1B076A375DA4Q38161583-76BD729E-BBF6-416E-AF86-0082E4555F5BQ38162894-1C3685BE-D26B-49C5-A5FF-575612E87679Q38206730-DED30571-8B3D-4BA1-BFB6-35E41B3DADE6Q38283656-C7E07E0A-31CE-4421-830B-38069A83B9BFQ39434012-34269E37-83AE-4355-B67D-BE40BD46FD96Q39945034-E0A35A3C-6870-45DA-9F3D-6F0BE4C20E00Q41435420-DF910F40-665B-43A5-B309-1E5C14768D21Q42379112-9A62A2AF-5401-4403-B87D-F49064DC7891Q47556433-F4610A5C-E47A-44B3-9162-0C5F11DC0CD9Q48049674-C78AFE08-89DF-4832-A2A8-64457C70B1D9Q49332642-4C5B561B-062C-467D-90F7-A077F576F0EEQ49721709-D45246FE-4B28-40D5-8DD6-D0546504127FQ51257285-D3407B42-791A-4C2E-AF9C-00AEFFDFE3E3Q53105439-B772D59B-64EB-4143-AA32-2109C965FE26
P2860
Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@en
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@nl
type
label
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@en
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@nl
prefLabel
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@en
Safety and efficacy of doxorub ...... nced hepatocellular carcinoma.
@nl
P2093
P1476
Safety and efficacy of doxorub ...... anced hepatocellular carcinoma
@en
P2093
Bassel F El-Rayes
Hasmukh J Prajapati
Hyun S Kim
John S Kauh
Shishir K Maithel
Zhengjia Chen
P304
P356
10.1016/J.JVIR.2012.11.026
P577
2013-01-29T00:00:00Z